Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rjk Biopharma Ltd

Clinical trials sponsored by Rjk Biopharma Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Gene therapy RJK002 injected into spine for ALS – first human test begins Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Gene therapy RJK002 injected into spine for ALS – first human test begins

Disease control Ongoing

This early-stage trial tests a single injection of RJK002, a gene therapy, into the spinal fluid of 9 people with ALS. The main goal is to see if it is safe and to find the best dose for future studies. Researchers will also track changes in daily function, but the trial is too s…

Phase 1 • Sponsor: RJK Biopharma Ltd • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC